Showing results (841-850 of 929) with videos related to
Sort By:
Pageof 93
The Journal of ECT|March 23, 2013
A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapyJohn D Matthews, Caleb J Siefert, Mark A Blais, et al.The American Journal of Psychiatry|April 9, 2016
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant DepressionJaskaran B Singh, Maggie Fedgchin, Ella J Daly, et al.The American Journal of Psychiatry|April 3, 2010
Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorderRoy H Perlis, Jordan W Smoller, Jayalakshmi Mysore, et al.Neuroimage|November 21, 2017
Harmonization of cortical thickness measurements across scanners and sitesJean-Philippe Fortin, Nicholas Cullen, Yvette I Sheline, et al.Brain Stimulation|October 15, 2017
Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.The International Journal of Neuropsychopharmacology|July 11, 2019
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)Maggie Fedgchin, Madhukar Trivedi, Ella J Daly, et al.Journal of Affective Disorders|October 5, 2018
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trialDawn F Ionescu, Kate H Bentley, Matthias Eikermann, et al.JAMA|March 23, 2006
Remissions in maternal depression and child psychopathology: a STAR*D-child reportMyrna M Weissman, Daniel J Pilowsky, Priya J Wickramaratne, et al.Journal of the American Heart Association|October 30, 2018
Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF TrialGene R Quinn, Anne S Hellkamp, Graeme J Hankey, et al.Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate ReceptorsEzio Bettini, Stephen M Stahl, Sara De Martin, et al.Pageof 93